Zydus Pivots To Multivariant COVID-19 Vaccine, Looks To Revlimid Opportunity

Board Approves Share Buyback

 
• By Vibha Ravi
  
Mutating coronavirus
Evolving COVID-19 Situation Is Presenting Business Challenges • Source: Alamy

More from Business

More from Scrip